MoonLake Immunotherapeutics - Ordinary Shares - Class A
XNAS: MLTX
MoonLake Immunotherapeutics - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart
about
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibit...
Read More
10.63
0.34
(3.30%)
2.1M
XNAS Volume
XNAS 07 Nov, 2025 4:30 PM (EST)
Board Meeting
The latest board meeting for MoonLake Immunotherapeutics - Ordinary Shares - Class A took place on 07 Nov 2025, for the purpose of MoonLake Immunotherapeutics Third Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
MoonLake Immunotherapeutics Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..